Like the small sweets children will be collecting this weekend, John Healey’s first Budget brought initial excitement, but was followed by mild disappointment.
Q3 UK biotech financing; Budget calls; early-stage funding gap; faster clinical trials; connecting Government and industry; digital and AI skills webinar
Chris Molloy on investment for BIA members; TIME’s Best Inventions; MHRA 2030 Strategy; Rare disease medicines review; Party conferences; TechBio; and BIA's AGM
Chris Molloy on investment in dementia; AI in healthcare; TechBio; BioJapan; bioProcessUK; Green, Conservative and Labour conferences; and BIA Board elections
Chris Molloy on the Labour Party conference; female biotech leaders in Edinburgh; Women in Biotech mentoring programme; Advanced Therapy Treatment Centre; BioSolutions Advisory Board; TechBio UK; and careers at BIA
£135 million for two life sciences funds, rare disease R&D, Beacon Therapeutics, Basecamp Research’s Series C, Birmingham Life Sciences Week, Liberal Democrat party conference, Women in Biotech Edinburgh
Causeway Sensors and Fusion Antibodies share a case study on how TITAN’s real-time, at-line analytics detected key harvest yield differences by Day 3, enabling early process intervention and smarter resource allocation.